6QIG
Metalloproteinase
Summary for 6QIG
Entry DOI | 10.2210/pdb6qig/pdb |
Descriptor | Antibody Light Chain, GLYCEROL, alpha-D-mannopyranose, ... (16 entities in total) |
Functional Keywords | metalloproteinase, blood clotting |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 3 |
Total formula weight | 118311.31 |
Authors | Kim, H.J.,Emsley, J. (deposition date: 2019-01-18, release date: 2019-09-04, Last modification date: 2024-11-06) |
Primary citation | Petri, A.,Kim, H.J.,Xu, Y.,de Groot, R.,Li, C.,Vandenbulcke, A.,Vanhoorelbeke, K.,Emsley, J.,Crawley, J.T.B. Crystal structure and substrate-induced activation of ADAMTS13. Nat Commun, 10:3781-3781, 2019 Cited by PubMed Abstract: Platelet recruitment to sites of blood vessel damage is highly dependent upon von Willebrand factor (VWF). VWF platelet-tethering function is proteolytically regulated by the metalloprotease ADAMTS13. Proteolysis depends upon shear-induced conformational changes in VWF that reveal the A2 domain cleavage site. Multiple ADAMTS13 exosite interactions are involved in recognition of the unfolded A2 domain. Here we report through kinetic analyses that, in binding VWF, the ADAMTS13 cysteine-rich and spacer domain exosites bring enzyme and substrate into proximity. Thereafter, binding of the ADAMTS13 disintegrin-like domain exosite to VWF allosterically activates the adjacent metalloprotease domain to facilitate proteolysis. The crystal structure of the ADAMTS13 metalloprotease to spacer domains reveals that the metalloprotease domain exhibits a latent conformation in which the active-site cleft is occluded supporting the requirement for an allosteric change to enable accommodation of the substrate. Our data demonstrate that VWF functions as both the activating cofactor and substrate for ADAMTS13. PubMed: 31439947DOI: 10.1038/s41467-019-11474-5 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.8 Å) |
Structure validation
Download full validation report